Share this

Carbapenem Resistance

Reference

  1. World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. February 27, 2017. Accessed November 6, 2024. https://www.who.int/en/news-room/detail/27-02-2017-whopublishes- list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.

References

  1. Xu L, Sun X, Ma X. Systematic review and meta‑analysis of mortality of patients infected with carbapenem‑resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16:18.
  2. Matos ECO, Andriolo RB, Rodrigues YC, Lima PDL, Carneiro ICDRS, Lima KVB. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis. Rev Soc Bras Med Trop. 2018;51(4):415-420.
  3. Lodise TP, Berger A, Altincatal A, et al. Antimicrobial resistance or delayed appropriate therapy—does one influence outcomes more than the other among patients with serious infections due to carbapenem-resistant versuscarbapenem-susceptible Enterobacteriaceae? Open Forum Infect Dis. 2019;6(6):ofz194.
  4. Tabak YP, Sung AH, Ye G, Vankeepuram L, Gupta V, McCann E. Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections. J Hosp Infect. 2019;102(1):37-44.
  5. Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobacteriaceae: a systematic review. Am J Infect Control. 2016;44(5):539-543.
  6. Bassetti M, Carnelutti A, Peghin M. Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti-Infect Ther. 2017;15(1):55-65.

References:

  1. Xu L, Sun X, Ma X. Systematic review and meta‑analysis of mortality of patients infected with carbapenem‑resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16:18.
  2. Matos ECO, Andriolo RB, Rodrigues YC, Lima PDL, Carneiro ICDRS, Lima KVB. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis. Rev Soc Bras Med Trop. 2018;51(4):415-420.

References:

  1. Xu L, Sun X, Ma X. Systematic review and meta‑analysis of mortality of patients infected with carbapenem‑resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16:18.
  2. Matos ECO, Andriolo RB, Rodrigues YC, Lima PDL, Carneiro ICDRS, Lima KVB. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis. Rev Soc Bras Med Trop. 2018;51(4):415-420.

References:

  1. Tabak YP, Sung AH, Ye G, Vankeepuram L, Gupta V, McCann E. Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections.J Hosp Infect. 2019;102:37-44.
  2. Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S,With Carbapenem-Resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2016 Mar;37(3):281-8. doi: 10.1017/ice.2015.298. Epub 2015 Dec 21. PMID: 26686227; PMCID: PMC4785868.

References:

  1. Tabak YP, Sung AH, Ye G, Vankeepuram L, Gupta V, McCann E. Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections.J Hosp Infect. 2019;102:37-44.
  2. Wang Q, Zhang Y, Yao X, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteria ceaenosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35(10):1679-1689.
  3. Messina JA, Cober E, Richter SS, et al. Hospital readmissions in patients with carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2016;37(3):281-288.

References

  1. Bassetti M, Carnelutti A, Peghin M. Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti-Infect Ther. 2017;15(1):55-65.

Reference

  1. Bassetti M, Carnelutti A, Peghin M. Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti-Infect Ther. 2017;15(1):55-65.

References

  1. Bassetti M, Carnelutti A, Peghin M. Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti-Infect Ther. 2017;15(1):55-65.

Reference:

Bassetti M, Carnelutti A, Peghin M. Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti-Infect Ther. 2017;15(1):55-65.

AE-NON-00509 | Exp 30 Sept 2026